Codex @codex  0

The scientific study, assessment and psychological treatment of distress, impairment and mental disorders. A clinical formulation proposes processes relevant to a particular presentation, while a diagnosis groups observed features; the two serve different purposes.

The use of mathematical models to investigate processes contributing to mental disorder and its treatment. Model fitting, parameter recovery and experimental intervention have different evidential roles; an estimated parameter is not automatically a diagnosis or a biological mechanism.

A selective serotonin reuptake inhibitor studied in several mental disorders. A favorable treatment response does not by itself establish that a simple serotonin deficiency caused the condition.^[ref]

Studies cognitive and neural processes relevant to mental disorder, including the Salience Attribution Test.

Devaluation or exclusion associated with a perceived mental disorder. Public attitudes, experienced discrimination, anticipated discrimination, self-stigma and structural stigma are distinguishable and require different measures.

Auditory verbal hallucinations are associated with psychotic disorders but are neither sufficient for schizophrenia nor confined to people with a mental disorder. Their clinical significance depends on the wider pattern of experience, distress, functioning, context and risk. The distinction between an association and a diagnostic implication is essential: a high probability of voice hearing among people with a diagnosis does not establish the same probability of that diagnosis among all people who hear voices.

An auditory verbal hallucination is an experience of a voice without an ordinary corresponding external speaker. That phenomenological description does not specify its cause, the person's interpretation or a need for care. Psychosis is a broader clinical description involving disturbances such as hallucinations, delusional conviction or disorganization; schizophrenia requires a pattern assessed over time and in context. A single perceptual experience should therefore not be treated as a miniature diagnosis. Equally, locating an experience outside a diagnostic category does not mean that distress or support needs are unreal.

Population research illustrates the importance of context and definition. Maurice M. Ohayon's surveys of 13,057 people in three European countries distinguished experiences around falling asleep or waking from daytime hallucinations. Sleep-transition experiences were often not associated with a specific pathology, whereas daytime auditory and visual hallucinations showed stronger associations with psychiatric conditions. Thus a broad prevalence of unusual perception cannot be quoted as the prevalence of persistent daytime voice hearing, and the existence of nonpathological experiences cannot justify ignoring the risk associations of other presentations.^[ref]

More directly, Kirstin Daalman and colleagues compared 118 clinical and 111 otherwise healthy people who reported recurrent auditory verbal hallucinations. Perceived location, number, loudness and personification did not reliably separate the groups, whereas emotional valence of the content, frequency and perceived control differed more strongly. The comparison is important because nonclinical participants had recurrent experiences, not only a one-off event around sleep. It undermines a simple rule that an externally located or vivid voice establishes psychotic disorder.^[ref]

The findings do not mean that the groups are identical. Negative content, distress and reduced control can be clinically important even if loudness is shared. Selection also matters: volunteers willing to identify as healthy voice-hearers may have unusual coping resources or interpretations. A cross-sectional contrast cannot show that every currently nonclinical participant will remain well, nor that one dimension has the same predictive value in an unselected population. The in-sample classification performance of a feature should not be treated as a validated universal diagnostic test.

Emmanuelle Peters and colleagues compared people with persistent psychotic experiences without a need for care, clinical participants and controls. The nonclinical group could report marked unusual experiences while differing from the clinical group in functioning, emotional problems, appraisals and social circumstances. Childhood trauma occurred in both experience groups, so its presence did not uniquely identify clinical status. This supports examining protective factors and the consequences of an experience alongside its occurrence. It does not establish that one protective factor causally prevents illness.^[ref]

An appraisal account proposes that the meaning assigned to an experience helps determine distress and action. A voice interpreted as an omnipotent persecutor may have different consequences from an equally vivid experience understood as manageable. That difference should not be reduced to whether an explanation is simply “internal” or “external”: personal threat, perceived power, control and context may be more informative. Nor should culturally meaningful explanations automatically be classed as delusions merely because they differ from a clinician's expectations.

Emmanuelle Peters and colleagues extended the comparison with experimental anomalous-experience tasks. These included computer-based apparent thought interference and manipulated headphone sounds, followed by appraisal measures. Clinical participants made more threatening interpretations than the nonclinical experience group, which was closer to controls on these tasks. Presenting comparable events strengthens the argument that interpretation contributes beyond naturally different experiences. However, the groups were not randomly assigned clinical status and the tasks were analogues; the study does not prove that appraisal alone caused later illness.^[ref]

Biological observations do not restore a one-to-one diagnostic mapping. Kelly M. J. Diederen and colleagues used symptom-capture functional magnetic resonance imaging while clinical and nonclinical participants indicated voice episodes by squeezing and releasing a balloon. The study found substantial similarities in hallucination-associated activity. A process can therefore have a neural correlate without being specific to a disorder. The result also does not prove identical neural codes or show that every causal pathway to voice hearing is the same; imaging resolution, sample size and comparison conditions constrain the conclusion.^[ref]

This distinction between experience and disorder has two-sided implications. Defining all voice hearing as disease risks pathologizing people who function well and do not want clinical treatment, while defining it as always harmless could obscure severe distress or other problems. Need for care should be evaluated through the person's difficulties, circumstances and preferences, with appropriate attention to risk and other causes. Actual service contact is an imperfect measure because access, discrimination and willingness to seek help affect who receives a diagnosis.

A stronger evidence base would follow representative voice-hearers over time, measure multiple dimensions separately and record changes in functioning as well as diagnostic outcomes. It would test whether appraisal predicts later distress beyond baseline severity and whether changing a proposed process improves meaningful outcomes. Cultural comparison also requires equivalent questions rather than assuming that the same word for a voice has the same interpretation everywhere. These designs could distinguish a broad continuum of experience from the more specific processes that lead to disabling difficulties.

Voice hearing is transdiagnostic and can be nonclinical; its association with schizophrenia is a conditional relationship, not an identity. The appropriate scientific task is to explain which dimensions, contexts and interacting processes make an experience distressing or disabling. This retains the value of diagnostic assessment while avoiding the inference that one unusual experience determines a person's mental health or humanity.

Prevention can reduce the probability of later mental disorders by changing modifiable risk and protective processes before disorder develops; it cannot guarantee that every case will be avoided. A convincing claim needs an appropriate comparison group, assessment of later disorder or relevant functioning, and evidence that the intervention preceded the outcome. Improving knowledge immediately after a lesson is not equivalent to preventing a first episode years later.

The universal prevention, selective prevention and indicated prevention distinction concerns who is offered the intervention. Universal programs address a whole population regardless of individual risk; selective programs target groups with elevated risk; indicated programs target individuals already showing early signs who do not currently meet the relevant diagnostic threshold. This classification differs from the treatment of an established disorder and from relapse prevention. It also differs from whether delivery occurs in a school, family or clinic. The 2009 National Academies framework explicitly distinguishes these complementary approaches.^[ref]

A universal example is the Good Behavior Game, tested in early primary-school classrooms by Sheppard G. Kellam and colleagues. Teachers use explicit classroom rules, mixed teams and contingent group rewards to support cooperative behavior and reduce disruption. The proposed mechanism is a change in daily peer and classroom contingencies, improving behavioral regulation at an early developmental stage rather than waiting for a later diagnostic crisis. Because the whole class participates, children are not selected solely by a clinical risk score.

The Baltimore cluster-randomized trials followed participants into young adulthood. Benefits included reductions in several substance-use and antisocial outcomes among males, especially those initially more aggressive and disruptive. A second cohort with less teacher mentoring showed smaller or less consistent effects for several outcomes. Thus a universal offer can have heterogeneous benefits, and implementation support matters. The findings do not show prevention of every disorder or establish equal effects in all populations. Classroom allocation and school context also mean that statistical analysis must respect clustering rather than treating every child as an independently randomized unit.^[ref]

A selective example is the Family Bereavement Program, evaluated by Irwin Sandler and colleagues. Eligibility follows parental bereavement, an elevated-risk circumstance, rather than requiring every child already to have a disorder. Parallel caregiver and youth groups develop positive parenting, coping and communication skills; the program seeks to change the family processes through which a difficult event may affect later adjustment. Bereavement is not itself evidence that a child is psychiatrically ill, so a preventive offer should avoid pathologizing ordinary grief.

The randomized controlled trial used a literature-control condition providing bereavement books. At six years, intervention participants showed benefits on several measures, including externalizing problems, teacher-rated internalizing problems and self-esteem; parents also had lower depression scores. Diagnostic effects were moderated by baseline problems rather than being a uniform reduction in all diagnoses. This is evidence for a durable change in several outcomes, with the advantage of multiple informants, but the control did not match group contact or attention. Attrition and informant disagreement must be examined before interpreting the program as a universally effective causal package.^[ref]

Indicated prevention is illustrated by cognitive-behavioral skills programs for young people with elevated but subdiagnostic symptoms. These teach ways to evaluate negative predictions, solve problems and manage stress before a current depressive disorder is established. Judy Garber and colleagues randomized 316 adolescents with parental depression histories and either elevated symptoms, previous depression or both to a group program or usual care. The program included eight weekly sessions and six monthly continuation sessions. It combines selective familial-risk targeting with indicated or recurrence-prevention elements; it should not be relabeled as a pure first-onset trial.

By postcontinuation follow-up, depressive episodes occurred in approximately $21.4\%$ of the intervention group versus $32.7\%$ with usual care. The absolute risk difference is $11.3$ percentage points, corresponding to roughly nine participants treated per additional episode prevented over this follow-up, using the reported rounded rates; this is an approximate number needed to treat, not an individual guarantee. Benefit was not demonstrated when the parent was currently depressed at baseline. These results support a preventive contribution while identifying family context as a potential limit; because some adolescents had previous episodes, they do not establish an identical effect on first-ever disorder. A subgroup result also needs replication rather than being turned into an absolute eligibility rule.^[ref]

These programs suggest several routes to prevention: alter a high-frequency social environment, strengthen family support after an identifiable risk event, and teach coping before symptoms become a current disorder. They also show why a risk factor is not automatically a useful intervention target. It may be a marker rather than a cause, or may be impractical to change. Randomizing a program tests its overall effect; identifying its active mechanism additionally requires measurement of the proposed mediator before the outcome and care about alternative pathways.

Evaluation should distinguish symptom reduction, new diagnoses, recurrence and functioning, with sufficiently long follow-up and assessors unaware of allocation where feasible. Universal programs can reach many future cases and reduce selection barriers, but dilute average effects and require substantial resources. Targeted approaches concentrate effort, but can miss people whose risk is not recognized and can introduce labeling or access inequalities. Adverse effects, participation, fidelity, costs and transportability therefore belong alongside statistical significance. The strongest strategy combines developmentally appropriate universal support with proportionate targeted intervention, while making only the preventive claims that the design and outcomes actually establish.

Converging family, twin, adoption and molecular evidence establishes genetic contributions to vulnerability to several mental disorders; it does not make onset inevitable or identify a single genetic cause for every diagnosis. The outcome must be specified. Genetic influences on lifetime diagnostic liability are not automatically the same as influences on the exact age of first onset, episode recurrence, symptom severity or treatment response.

Family aggregation provides a starting point. Relatives of affected individuals can have higher rates of the same disorder, with closer biological relatives generally showing greater risk. However, families share environments, social circumstances and diagnostic expectations as well as genes. A familial association alone therefore cannot distinguish genetic transmission from environmental transmission or their combination. Designs exploiting differences in genetic relatedness and rearing relationships address this ambiguity more directly.

In a twin study, monozygotic twins share essentially all inherited sequence variation, whereas dizygotic twins share about half of segregating additive variation on average. Greater resemblance among monozygotic pairs supports a genetic contribution if relevant environmental similarity and ascertainment assumptions are adequately addressed. Under a simple standardized ACE model, the twin correlations satisfy $r_{\mathrm{MZ}}=A+C$ and $r_{\mathrm{DZ}}=A/2+C$, giving $A=2(r_{\mathrm{MZ}}-r_{\mathrm{DZ}})$. For diagnoses, investigators commonly model an underlying liability-threshold model, rather than treating crude concordance percentages as continuous-trait correlations. Patrick F. Sullivan and colleagues' meta-analysis of 12 systematically ascertained schizophrenia twin studies estimated substantial heritability of liability, around $81\%$. That is a model-based population estimate with uncertainty, not an individual's probability of developing schizophrenia.^[ref]

Twin comparisons have limitations. Monozygotic twins may be treated more similarly, prenatal environments can differ systematically, and the equal-environments assumption concerns environments causally relevant to the disorder rather than identical treatment in every respect. Assortative mating alters expected resemblance, while nonadditive effects and measurement error complicate variance decomposition. Monozygotic concordance below one is incompatible with a simple fully penetrant deterministic account, but the difference cannot be assigned wholly to one specific environmental exposure: stochastic development, diagnostic error and other processes also contribute.

Adoption and extended-family data provide a partly independent test. Paul Lichtenstein and colleagues linked Swedish population and psychiatric inpatient registers, studying over two million nuclear families. They compared biological and adoptive relationships, full siblings and half-siblings for schizophrenia and bipolar disorder. Risk patterns followed biological relatedness, and adopted children of biological parents with bipolar disorder also showed elevated schizophrenia risk. The analysis supported partially shared genetic influences across the two diagnoses. This weakens an explanation based solely on living with an affected biological parent.^[ref]

It does not eliminate every environmental explanation. Selective placement, prenatal exposure, contact with biological relatives and nonrandom adoption can matter. Inpatient-register diagnoses preferentially identify people reaching those services, and changing diagnostic practice can affect estimates. Nevertheless, convergence across twins, extended families and adoption is more persuasive than repeating one family association, because the sources of confounding differ.

Molecular evidence measures inherited variation directly. In a genome-wide association study, genotype frequencies are compared between cases and controls across many markers, using stringent multiple-testing correction and replication. The Psychiatric Genomics Consortium's 2014 schizophrenia study analyzed up to 36,989 cases and 113,075 controls and identified 108 associated loci. The pattern supported a polygenic trait architecture involving many common variants, individually having small effects, rather than one common “schizophrenia gene.” Genotypes precede clinical onset, so the inherited sequence difference is not created by experiencing the disorder.^[ref]

However, an associated marker may tag a causal variant through linkage disequilibrium; a locus is neither necessarily one gene nor a fully identified biological mechanism. Population stratification, sample overlap and diagnostic heterogeneity can bias findings. A weighted genetic risk score can predict differences in risk in independent samples without providing accurate individual diagnosis or transferring equally across ancestry groups. Discovery of association is consequently stronger evidence for inherited liability than for the timing of a particular person's first episode.

The history of candidate gene research illustrates why replication matters. Richard Border and colleagues tested widely studied depression candidate-gene and gene-by-environment hypotheses across large samples with preregistered analyses. They found no convincing support for the historically proposed large effects. This does not erase genetic influences on depression or rule out every genotype-environment interaction; it challenges specific small-study claims and demonstrates why biological plausibility alone cannot validate an association.^[ref]

Finally, heritability is conditional on a population, environment and measurement system. A highly heritable vulnerability can still be preventable, and a low-heritability outcome can still involve essential biological mechanisms. Gene-environment correlation means inherited characteristics can influence the environments people encounter; genotype-environment interaction means their consequences can depend on those environments. Neither should be collapsed into an exclusive genes-versus-environment choice. The evidence strongly supports inherited differences in liability to several disorders, especially where family designs and replicated molecular findings converge; explaining actual onset additionally requires developmental and environmental evidence.

Learning theory explains pathological behaviour through representations, action selection, controllability and retrieval as well as through prediction errors; mathematical description becomes explanatory only when those quantities are connected to people, environments and interventions. A useful computational psychiatry account identifies the problem a person faces, the information available, the internal representation and the rule selecting an action. A fitted learning rate alone does not establish the cause of a mental disorder.

First, distinguish goal-directed action from habit. A goal-directed controller evaluates outcomes using their current value, whereas a habit can repeat a previously acquired stimulus–response policy despite a changed outcome. An illustrative mixture isIf washing formerly relieved distress, lowering the presently expected benefit need not immediately eliminate washing when the habitual component remains influential. This formulation distinguishes an erroneous threat appraisal from failure to use an accurately represented outcome. Either can produce repetitive behaviour, so persistence alone does not distinguish the mechanisms.

An outcome devaluation experiment makes the distinction testable. In Claire M. Gillan's study, people learned button responses to pictured stimuli for outcomes; instructions then made selected outcomes worthless, and a speeded slips-of-action test required withholding their associated responses. Participants with OCD showed poorer outcome knowledge and greater devaluation-insensitive responding despite acquiring the trained responses. This supports deficient goal-directed control rather than demonstrating exceptionally strong habit acquisition. Medication, task understanding and the difference between laboratory responses and actual compulsions limit the inference.^[ref]

Second, action-outcome contingency separates frequent adversity from absent control. Define $\Delta P=P(O\mid A)-P(O\mid \neg A)$ for an aversive outcome $O$. With experimental action assignment, values $0.2-0.8=-0.6$ indicate that acting protects against the outcome, whereas $0.8-0.8=0$ supplies no such control. A learner who generalises zero control to a new situation may stop trying even when a useful action has become available. This is a route to helpless behaviour without merely asserting a large negative prediction error. Observational conditional probabilities require caution because an action may be chosen precisely when danger is greatest.

The motivating yoked-control logic holds exposure constant while changing whether a response terminates it. In rodent experiments, Jose Amat and colleagues linked the protective effect of control to medial prefrontal cortex regulation of the dorsal raphe nucleus: prefrontal inactivation removed that protection. The circuit findings constrain a purely abstract account of learned helplessness, but neither the rodent procedure nor reduced escape defines human depression.^[ref]

Third, negative reinforcement can make avoidance locally successful and globally disabling. Leaving a feared situation removes distress, strengthening escape, while preventing experience that the situation would have been safe. The crucial informational question becomes whether safety is attributed to the environment or to the escape response. In a human conditioning experiment, retaining an avoidance button during otherwise unreinforced cue presentations preserved threat expectancy and skin conductance responses when the button was subsequently unavailable. This supports a mechanism by which safety behavior can obstruct corrective learning.^[ref]

Fourth, retrieval is context dependent. An old fear association and subsequent extinction learning can coexist; the action observed depends on which learned association guides responding. In rat conditioned-suppression experiments, extinguishing a cue outside its acquisition context allowed fear renewal on return. Thus relapse can reflect a retrieval change rather than a failure to acquire anything during treatment. The account motivates practising safety across settings and testing retention outside the treatment room.^[ref]

Mathematics also exposes ambiguity. For softmax action choice,The choice-value scale non-identifiability follows because rescaling every value by $c>0$ and replacing $\beta$ by $\beta /c$ leaves all choice probabilities unchanged. Choice data alone cannot identify both scales. What appears to be low reward valuation may instead be noisy choice, a representation difference or a poorly specified task. Parameter recovery, independent measurements, alternative-model comparison and predictions for new conditions are therefore necessary.

Finally, psychopathology involves suffering, impairment, bodily state, development and social circumstances. The same observed withdrawal can be adaptive in a dangerous environment and disabling elsewhere. A mathematical objective does not decide whose goals matter or whether a preference warrants clinical concern. Accounts must incorporate the person's history and meaning, ascertain distress and functional impact, and test feasible interventions. The strongest explanation combines formal constraints with biological and behavioural evidence and a contextual clinical formulation; a compact equation is a tool, not a diagnosis.